Table 2 EQ-5D-5L and EORTC QLQ-C30 sample demographic and clinical characteristics
From: Estimating the minimally important difference for the EQ-5D-5L and EORTC QLQ-C30 in cancer
Characteristics | EQ-5D-5L analytic sample (n = 464) | EORTC QLQ-C30 analytic sample (N = 799) | ||
|---|---|---|---|---|
Mean | SD | Mean | SD | |
Age | 63 | 11 | 63 | 12 |
n | % of total N of patients | n | % of total N of patients | |
Sex | ||||
Female | 260 | 56% | 442 | 55% |
Number of follow-ups | ||||
1 | 27 | 6% | 45 | 6% |
2 | 70 | 15% | 154 | 19% |
3 | 117 | 25% | 219 | 27% |
4 | 177 | 38% | 206 | 26% |
5+ | 73 | 16% | 170 | 22% |
Cancer site at first diagnosis | ||||
Breast | 161 | 35% | 278 | 35% |
Genitourinary | 106 | 23% | 178 | 22% |
Head and neck | 63 | 14% | 95 | 12% |
Colorectal | 60 | 13% | 101 | 13% |
Lung | 25 | 5% | 45 | 6% |
All others | 46 | 10% | 99 | 12% |
Missing | 3 | 0.7% | 3 | 0.38% |
Cancer stage | ||||
Unknown | 8 | 2% | 16 | 2% |
Distant metastases | 12 | 3% | 50 | 6% |
Regional lymph nodes | 108 | 23% | 188 | 24% |
Invasion of adjacent tissue or organs | 44 | 9% | 70 | 9% |
Localised to the tissue of origin | 262 | 56% | 437 | 55% |
Missing | 30 | 6% | 38 | 5% |